The virus has reached the generic // A competitor to Ingavirin may appear on the market
[ad_1]
One of the most popular antiviral drugs in Russia, Ingavirin from Valenta Pharm, included in the treatment protocols for coronavirus, may have its first generic version in Russia. Its release is planned by Basis-Metigreens together with the Indian Synmedic. The timing is not specified, but permission for clinical trials was received before the end of 2024. Sales of Ingavirin this year exceeded 5 billion rubles. The original product is protected by a number of patents in the Russian Federation and the EAEU. This will not prevent an analogue developer from launching its drug, experts say, but the experience of manufacturers of generics of other drugs in the category shows that it can be difficult to compete on price alone.
[ad_2]
Source link
